197 related articles for article (PubMed ID: 26378022)
1. Golgi protein 73 activation of MMP-13 promotes hepatocellular carcinoma cell invasion.
Jin D; Tao J; Li D; Wang Y; Li L; Hu Z; Zhou Z; Chang X; Qu C; Zhang H
Oncotarget; 2015 Oct; 6(32):33523-33. PubMed ID: 26378022
[TBL] [Abstract][Full Text] [Related]
2. GP73 promotes epithelial-mesenchymal transition and invasion partly by activating TGF-β1/Smad2 signaling in hepatocellular carcinoma.
Yang Y; Liu Q; Li Z; Zhang R; Jia C; Yang Z; Zhao H; Ya S; Mao R; Ailijiang T; Bao Y; Zhang H
Carcinogenesis; 2018 Jul; 39(7):900-910. PubMed ID: 29365054
[TBL] [Abstract][Full Text] [Related]
3. Fibulin-5 inhibits hepatocellular carcinoma cell migration and invasion by down-regulating matrix metalloproteinase-7 expression.
Tu K; Dou C; Zheng X; Li C; Yang W; Yao Y; Liu Q
BMC Cancer; 2014 Dec; 14():938. PubMed ID: 25494879
[TBL] [Abstract][Full Text] [Related]
4. Knockdown of Golgi phosphoprotein 73 blocks the trafficking of matrix metalloproteinase-2 in hepatocellular carcinoma cells and inhibits cell invasion.
Liu Y; Zhang X; Zhou S; Shi J; Xu Y; He J; Lin F; Wei A; Zhou L; Chen Z
J Cell Mol Med; 2019 Apr; 23(4):2399-2409. PubMed ID: 30677226
[TBL] [Abstract][Full Text] [Related]
5. mTORC1 Up-Regulates GP73 to Promote Proliferation and Migration of Hepatocellular Carcinoma Cells and Growth of Xenograft Tumors in Mice.
Chen X; Wang Y; Tao J; Shi Y; Gai X; Huang F; Ma Q; Zhou Z; Chen H; Zhang H; Liu Z; Sun Q; Peng H; Chen R; Jing Y; Yang H; Mao Y; Zhang H
Gastroenterology; 2015 Sep; 149(3):741-52.e14. PubMed ID: 25980751
[TBL] [Abstract][Full Text] [Related]
6. Knockdown of Golgi phosphoprotein 2 inhibits hepatocellular carcinoma cell proliferation and motility.
Liu Y; Zhang X; Sun T; Jiang J; Li Y; Chen M; Wei Z; Jiang W; Zhou L
Oncotarget; 2016 Apr; 7(16):21404-15. PubMed ID: 26870893
[TBL] [Abstract][Full Text] [Related]
7. Upregulated FoxM1 expression induced by hepatitis B virus X protein promotes tumor metastasis and indicates poor prognosis in hepatitis B virus-related hepatocellular carcinoma.
Xia L; Huang W; Tian D; Zhu H; Zhang Y; Hu H; Fan D; Nie Y; Wu K
J Hepatol; 2012 Sep; 57(3):600-12. PubMed ID: 22613004
[TBL] [Abstract][Full Text] [Related]
8. Aberrant expression of Golgi protein 73 is indicative of a poor outcome in hepatocellular carcinoma.
Jiang K; Li W; Shang S; Sun L; Guo K; Zhang S; Liu Y
Oncol Rep; 2016 Apr; 35(4):2141-50. PubMed ID: 26820712
[TBL] [Abstract][Full Text] [Related]
9. Promotion of hepatocellular carcinoma metastasis through matrix metalloproteinase activation by epithelial-mesenchymal transition regulator Twist1.
Zhao XL; Sun T; Che N; Sun D; Zhao N; Dong XY; Gu Q; Yao Z; Sun BC
J Cell Mol Med; 2011 Mar; 15(3):691-700. PubMed ID: 20219012
[TBL] [Abstract][Full Text] [Related]
10. Suppressive effects of microRNA-16 on the proliferation, invasion and metastasis of hepatocellular carcinoma cells.
Wu WL; Wang WY; Yao WQ; Li GD
Int J Mol Med; 2015 Dec; 36(6):1713-9. PubMed ID: 26499886
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological significance of miR-27b targeting Golgi protein 73 in patients with hepatocellular carcinoma.
Liang H; Ai-Jun J; Ji-Zong Z; Jian-Bo H; Liang Z; Yong-Xiang Y; Chen Y
Anticancer Drugs; 2019 Feb; 30(2):186-194. PubMed ID: 30418194
[TBL] [Abstract][Full Text] [Related]
12. S100A4 regulates migration and invasion in hepatocellular carcinoma HepG2 cells via NF-κB-dependent MMP-9 signal.
Zhang J; Zhang DL; Jiao XL; Dong Q
Eur Rev Med Pharmacol Sci; 2013 Sep; 17(17):2372-82. PubMed ID: 24065232
[TBL] [Abstract][Full Text] [Related]
13. Silencing of GP73 inhibits invasion and metastasis via suppression of epithelial-mesenchymal transition in hepatocellular carcinoma.
Yang Y; Liu Q; Zhang H; Zhao H; Mao R; Li Z; Ya S; Jia C; Bao Y
Oncol Rep; 2017 Feb; 37(2):1182-1188. PubMed ID: 28075476
[TBL] [Abstract][Full Text] [Related]
14. MiR-559 targets GP73 to suppress proliferation and invasion of hepatocellular carcinoma in vitro.
Zheng XS; Liu HJ; Zhang LL; Li H; Wang CJ; Xin YJ; Hao R
Kaohsiung J Med Sci; 2020 Oct; 36(10):793-798. PubMed ID: 32492286
[TBL] [Abstract][Full Text] [Related]
15. Reciprocal activation between MMP-8 and TGF-β1 stimulates EMT and malignant progression of hepatocellular carcinoma.
Qin G; Luo M; Chen J; Dang Y; Chen G; Li L; Zeng J; Lu Y; Yang J
Cancer Lett; 2016 Apr; 374(1):85-95. PubMed ID: 26872724
[TBL] [Abstract][Full Text] [Related]
16. Insulin-like growth factor binding protein-1 inhibits cancer cell invasion and is associated with poor prognosis in hepatocellular carcinoma.
Dai B; Ruan B; Wu J; Wang J; Shang R; Sun W; Li X; Dou K; Wang D; Li Y
Int J Clin Exp Pathol; 2014; 7(9):5645-54. PubMed ID: 25337205
[TBL] [Abstract][Full Text] [Related]
17. ADAM10 is overexpressed in human hepatocellular carcinoma and contributes to the proliferation, invasion and migration of HepG2 cells.
Yuan S; Lei S; Wu S
Oncol Rep; 2013 Oct; 30(4):1715-22. PubMed ID: 23912592
[TBL] [Abstract][Full Text] [Related]
18. Epimorphin promotes human hepatocellular carcinoma invasion and metastasis through activation of focal adhesion kinase/extracellular signal-regulated kinase/matrix metalloproteinase-9 axis.
Jia YL; Shi L; Zhou JN; Fu CJ; Chen L; Yuan HF; Wang YF; Yan XL; Xu YC; Zeng Q; Yue W; Pei XT
Hepatology; 2011 Nov; 54(5):1808-18. PubMed ID: 22045676
[TBL] [Abstract][Full Text] [Related]
19. Prostaglandin E2 promotes the cell growth and invasive ability of hepatocellular carcinoma cells by upregulating c-Myc expression via EP4 receptor and the PKA signaling pathway.
Xia S; Ma J; Bai X; Zhang H; Cheng S; Zhang M; Zhang L; Du M; Wang Y; Li H; Rong R; Shi F; Yang Q; Leng J
Oncol Rep; 2014 Oct; 32(4):1521-30. PubMed ID: 25109834
[TBL] [Abstract][Full Text] [Related]
20. GP73 N-glycosylation at Asn144 reduces hepatocellular carcinoma cell motility and invasiveness.
Jiang K; Li W; Zhang Q; Yan G; Guo K; Zhang S; Liu Y
Oncotarget; 2016 Apr; 7(17):23530-41. PubMed ID: 26993603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
